CD5CAR-NK cells for refractory invasive mold disease

2025-524638-24-00 Protocol CD5CAR-NK Human pharmacology (Phase I) - First administration to humans Ongoing, recruiting

Start 17 Jun 2026 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites · Protocol CD5CAR-NK

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ongoing, recruiting
Participants planned 10
Countries 1
Sites 1

refractory invasive mold disease

Key facts

Sponsor
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Bacterial Infections and Mycoses [C01]
Trial duration
17 Jun 2026 → ongoing
Decision date (initial)
2026-05-04
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

refractory invasive mold disease

VersionLevelCodeTermSystem organ class
20.0 PT 10017533 Fungal infection 100000004862

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer

Sponsor organisation
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Address
Calle Rosellon 149-153
City
Barcelona
Postcode
08036
Country
Spain

Scientific contact point

Organisation
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Contact name
Dra. Carolina Garcia

Public contact point

Organisation
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Contact name
Dra. Carolina Garcia

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Spain Ongoing, recruiting 10 1
Rest of world 0

Investigational sites

Spain

1 site · Ongoing, recruiting
Hospital Clinic De Barcelona
Infectious Diseases, Calle Villarroel 170, 08036, Barcelona

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Spain 2026-06-17 2026-06-17

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2026-01-16 Spain Acceptable
2026-04-27
2026-05-04